Definium Therapeutics Inc. Common Shares vs Elanco Animal Health Incorporated Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Elanco Animal Health Incorporated Common Stock trades at $22.5 (market cap $11.17B). The key difference: Elanco Animal Health Incorporated Common Stock is far larger — about 2.4× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Elanco Animal Health Incorporated Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Elanco Animal Health Incorporated Common Stock for 0 Days on average.
| DFTX | ELAN | |
|---|---|---|
Market Cap | $4.71B | $11.17B |
Volume | 1,966,636 | 4,196,242 |
Sector | Health | Health |
52-Week High | $48.45 | $26.84 |
52-Week Low | $10.68 | $19.76 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $14.56B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →